TENS for Suction Evacuation for Termination of 1st Trimester Pregnancies
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03494842|
Recruitment Status : Unknown
Verified April 2018 by KEEDON WONG, Queen Mary Hospital, Hong Kong.
Recruitment status was: Enrolling by invitation
First Posted : April 11, 2018
Last Update Posted : April 11, 2018
|Condition or disease||Intervention/treatment||Phase|
|Pregnancy, Abdominal Termination of Pregnancy Pain, Nerve||Device: Transcutaneous nerve stimulation (TENS) Device: Placebo Transcutaneous nerve stimulation (TENS)||Not Applicable|
Suction evacuation is a minor gynecological procedure commonly performed at an outpatient setting for termination of pregnancy. Although it is a simple surgical procedure lasting 5-10 min and can be done under various methods of pain control, 78-97% of women still report at least moderate procedural pain, especially during injection of paracervical block, cervical dilation, suction aspiration and postoperatively with uterine cramping. In addition, those pharmacological analgesic methods are often associated with numerous adverse effects and cannot be applicable to all women.
The transcutaneous nerve stimulation (TENS) method is commonly used to treat labour pain. It is an inexpensive, quick, easy to use and noninvasive pain relief method. A recent study by Lison et al. on TENS for office hysteroscopy demonstrated a significant decrease in pain scores when compared to control and placebo groups.
The rationale of TENS lies in achieving pain reduction when electric stimulation alters the nociceptive transmission in the dorsal horn of the spinal cord; this means the electrode has to be adequately applied in the right receptive field of the body to achieve pain control. For the setting of TENS there is evidence supporting superior pain relief by random high frequencies TENS over fixed frequency. Increasing the pulse duration to above 250 microseconds also produces better analgesics effect.
In suction evacuation, the nerve roots of T10-L1 and S2-S4 becomes relevant as they correspond to the nerve supply to the whole uterus and cervix. Lison et al placed electrodes at these levels parallel to the spinal cord in their study and have instructed their subjects to increase the TENS intensity to the maximum nonpainful level, allowing further increase when their stimulus perception decrease as a result of nerve accommodation.
Its use in suction evacuation however, remains undetermined as there is no published study in this area.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||170 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Masking Description:||After the written informed consent is obtained, subjects will be randomly allocated into one of the two groups: (a) the active TENS group and (b) the placebo TENS group.|
|Official Title:||A Doubled Blinded Randomised Controlled Trial of Conscious Sedation With Transcutaneous Nerve Stimulation for Pain Relief During Suction Evacuation for Termination of First Trimester Pregnancies|
|Estimated Study Start Date :||April 26, 2018|
|Estimated Primary Completion Date :||January 22, 2020|
|Estimated Study Completion Date :||March 22, 2020|
Active Comparator: the active TENS group
Transcutaneous nerve stimulation (TENS)
Device: Transcutaneous nerve stimulation (TENS)
The active TENS unit (delivers electrical stimulation) with indicator light
Other Name: the active TENS group
Placebo Comparator: the placebo TENS group
Placebo Transcutaneous nerve stimulation (TENS)
Device: Placebo Transcutaneous nerve stimulation (TENS)
the placebo TENS unit (delivers no electrical stimulation) with indicator light
Other Name: the placebo TENS group
- To assess the change of 100-point visual analogue pain scale in 3 time points [ Time Frame: Patient will be asked for the pain intensity by using the 100 mm linear VAS 5 minutes before receiving the active TENS/ placebo TENS before the start of suction evacuation, reassess 20 minutes later and 1 hour after operation. ]To measure patient's pain intensity before and after suction TOP by using The Visual Analogue Scale (VAS) consists of a straight line length of 100 mm with the endpoints defining extreme limits such as 'no pain at all' and 'pain as bad as it could be'. The patient is asked to mark his pain level on the line between the two endpoints. The distance between 'no pain at all' and the mark then defines the subject's pain. This tool was first used in psychology by Freyd in 1923.
- To assess the change of Anxiety level of the patients in 3 time points by using State-Trait Anxiety Inventory Questionnaire to record patient's anxiety level. [ Time Frame: Patient will be asked for the anxiety level by using STAI 5 minutes before receiving the active TENS/ placebo TENS before the start of suction evacuation, reassess 20 minutes later and 1 hour after operation. ]To record patient's anxiety level for comparison
- To assess the difficulty of the operation [ Time Frame: The surgeon will be asked to fill the assessment form right after the suction evacuation operation immediately. ]The surgeon will assess the difficulty of the operation by using LEVEL OF SEDATION AND DIFFICULTY OF OPERATION ASSESSMENT FORM (proposed by Ramsay et al.)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03494842
|Queen Mary Hospital|
|Hong Kong, Hong Kong|
|Principal Investigator:||Keedon Wong, MBBS||Queen Mary Hospital, Hong Kong|